HCPWP plenary meeting September 2025, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2025, 14:00 (CEST) to 23 September 2025, 17:30 (CEST)

Submitted by Anonymous (not verified) on 18 August 2025 - 15:35

HCPWP plenary meeting September 2025, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2025, 14:00 (CEST) to 23 September 2025, 17:30 (CEST)

PCWP/HCPWP joint meeting September 2025, European Medicines Agency, Amsterdam, the Netherlands, from 24 September 2025, 09:00 (CEST) to 24 September 2025, 16:10 (CEST)

Submitted by Anonymous (not verified) on 18 August 2025 - 14:11

PCWP/HCPWP joint meeting September 2025, European Medicines Agency, Amsterdam, the Netherlands, from 24 September 2025, 09:00 (CEST) to 24 September 2025, 16:10 (CEST)

PCWP plenary meeting September 2025, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2025, 08:45 (CEST) to 23 September 2025, 12:00 (CEST)

Submitted by Anonymous (not verified) on 18 August 2025 - 13:53

PCWP plenary meeting September 2025, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2025, 08:45 (CEST) to 23 September 2025, 12:00 (CEST)

Annual open meeting of the European Network of Paediatric Research at EMA (Enpr-EMA) November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 November 2025, 09:00 (CET) to 20 November 2025, 16:45 (CET)

Submitted by Anonymous (not verified) on 18 August 2025 - 13:45

Annual open meeting of the European Network of Paediatric Research at EMA (Enpr-EMA) November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 November 2025, 09:00 (CET) to 20 November 2025, 16:45 (CET)

Human medicines European public assessment report (EPAR): Fluenz Tetra, influenza vaccine (live attenuated, nasal), Date of authorisation: 04/12/2013, Revision: 24, Status: Withdrawn

Submitted by Anonymous (not verified) on 14 August 2025 - 17:10

Human medicines European public assessment report (EPAR): Fluenz Tetra, influenza vaccine (live attenuated, nasal), Date of authorisation: 04/12/2013, Revision: 24, Status: Withdrawn

Human medicines European public assessment report (EPAR): Sixmo, buprenorphine, Date of authorisation: 19/06/2019, Revision: 6, Status: Withdrawn

Submitted by Anonymous (not verified) on 14 August 2025 - 17:00

Human medicines European public assessment report (EPAR): Sixmo, buprenorphine, Date of authorisation: 19/06/2019, Revision: 6, Status: Withdrawn

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness